RecallRadar

FDA Device recall Z-0028-2022

TECNIS Eyhance IOLs are permanent intraocular implants intended for implantation in the capsular bag

On 2021-10-13 the FDA classified a Class II recall of TECNIS Eyhance IOLs are permanent intraocular implants intended for implantation in the capsular bag by Johnson And Johnson Surgical Vision, citing nonconforming product was distributed in error. Product was nonconforming due endotoxin levels higher than both the Firm's internal endotoxin specification limit and the FDA recom….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0028-2022
ClassificationClass II
Statusterminated
Initiated2021-08-06
Published2021-10-13
Last updated2026-09-13 11:56 UTC
CompanyJohnson And Johnson Surgical Vision
DistributionUS

Product

TECNIS Eyhance IOLs are permanent intraocular implants intended for implantation in the capsular bag. The TECNIS Simplicity Delivery System is designed as a single-use disposable preloaded modular cartridge that functions as both the primary packaging and as a sterile, disposable insertion system for delivering the IOL into the eye during cataract surgery.

Reason

Nonconforming product was distributed in error. Product was nonconforming due endotoxin levels higher than both the Firm's internal endotoxin specification limit and the FDA recommended endotoxin specification limit. Product was released in error based on the results of additional testing performed during the investigation into release testing nonconformance.

Identifiers

code_infoModel: DIU225U050 UDI Code: (01)05050474745831(17)240414(21)5248142104 Production Order Number: 900001985625 Serial Number: 5248142104

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0028-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.